Skip to content

Research Protocol for the Clinical Application of ICG Fluorescence Imaging Technology in Laparoscopic Adrenal Tumor Resection

Research Protocol for the Clinical Application of ICG Fluorescence Imaging Technology in Laparoscopic Adrenal Tumor Resection

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600118282
Enrollment
Unknown
Registered
2026-02-04
Start date
2026-01-13
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adrenal Tumor

Interventions

ICG group:ICG fluorescence imaging technology was used for intraoperative navigation. Intraoperatively, 25 mg of indocyanine green (ICG, provided by Dandong Medical Innovation Pharmaceutical Co., Ltd.
Non-ICG Group:Laparoscopic adrenal tumor resection is performed routinely, with no indocyanine green (ICG) administered intraoperatively.

Sponsors

Chongqing Ninth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged between 20 and 80 years old; 2. Preoperative abdominal computed tomography (CT) or magnetic resonance imaging (MRI) examination confirming a unilateral adrenal tumor; 3. Maximum diameter of the tumor < 6 cm; 4. Completion of preoperative adrenal hormone level tests, including tests for cortisol, aldosterone, renin, catecholamines, etc.; 5. Patients in good general condition, without obvious surgical contraindications, and able to tolerate surgery; 6. Voluntary participation in this clinical study and signing of the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Preoperative imaging examinations suggest bilateral adrenal tumors; 2. A history of previous retroperitoneal surgery on the same side; 3. A history of previous adrenal surgery; 4. Patients with severe primary diseases such as cardiovascular and cerebrovascular diseases, hematopoietic system diseases, or mental illnesses; 5. Patients with a severe allergic constitution; patients allergic to iodine; 6. Pregnant women and lactating women;

Design outcomes

Primary

MeasureTime frame
Adrenal tumor localization time;Total surgery time;Intraoperative blood loss;

Secondary

MeasureTime frame
Fluorescence visualization rate of adrenal tumors;Preoperative and postoperative serum cortisol ratio;Total postoperative drainage volume;Postoperative hospital stay duration;

Countries

China

Contacts

Public ContactZhang Jie

Chongqing Ninth People's Hospital

zhangjie320320@163.com+86 158 2382 6710

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026